• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症代谢物生物标志物的系统评价。

A systematic review of metabolite biomarkers of schizophrenia.

机构信息

RCSI Psychiatry, Royal College of Surgeons in Ireland, Education and Research Centre Beaumont Hospital, Dublin 9, Ireland; Institute of Food & Health, UCD School of Agriculture and Food Science, University College Dublin, Dublin 4, Ireland.

Institute of Food & Health, UCD School of Agriculture and Food Science, University College Dublin, Dublin 4, Ireland.

出版信息

Schizophr Res. 2018 May;195:32-50. doi: 10.1016/j.schres.2017.09.021. Epub 2017 Sep 22.

DOI:10.1016/j.schres.2017.09.021
PMID:28947341
Abstract

Current diagnosis of schizophrenia relies exclusively on the potentially subjective interpretation of clinical symptoms and social functioning as more objective biological measurement and medical diagnostic tests are not presently available. The use of metabolomics in the discovery of disease biomarkers has grown in recent years. Metabolomic methods could aid in the discovery of diagnostic biomarkers of schizophrenia. This systematic review focuses on biofluid metabolites associated with schizophrenia. A systematic search of Web of Science and Ovid Medline databases was conducted and 63 studies investigating metabolite biomarkers of schizophrenia were included. A review of these studies revealed several potential metabolite signatures of schizophrenia including reduced levels of essential polyunsaturated fatty acids (EPUFAs), vitamin E and creatinine; and elevated levels of lipid peroxidation metabolites and glutamate. Further research is needed to validate these biomarkers and would benefit from large cohort studies and more homogeneous and well-defined subject groups.

摘要

目前对精神分裂症的诊断仅依赖于对临床症状和社会功能的潜在主观解释,因为目前尚无更客观的生物学测量和医学诊断测试。近年来,代谢组学在发现疾病生物标志物方面的应用不断增加。代谢组学方法可以帮助发现精神分裂症的诊断生物标志物。本系统评价重点关注与精神分裂症相关的生物流体代谢物。对 Web of Science 和 Ovid Medline 数据库进行了系统搜索,纳入了 63 项研究精神分裂症代谢物生物标志物的研究。对这些研究的回顾揭示了一些潜在的精神分裂症代谢物特征,包括必需多不饱和脂肪酸 (EPUFAs)、维生素 E 和肌酸水平降低,脂质过氧化代谢物和谷氨酸水平升高。需要进一步研究来验证这些生物标志物,并且从大型队列研究和更同质和明确界定的研究对象组中获益。

相似文献

1
A systematic review of metabolite biomarkers of schizophrenia.精神分裂症代谢物生物标志物的系统评价。
Schizophr Res. 2018 May;195:32-50. doi: 10.1016/j.schres.2017.09.021. Epub 2017 Sep 22.
2
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
3
Metabolomic biomarkers of low BMD: a systematic review.低骨密度的代谢组学生物标志物:系统评价。
Osteoporos Int. 2021 Dec;32(12):2407-2431. doi: 10.1007/s00198-021-06037-8. Epub 2021 Jul 26.
4
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
7
Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation.用于血尿调查的诊断测试和算法:系统评价与经济评估
Health Technol Assess. 2006 Jun;10(18):iii-iv, xi-259. doi: 10.3310/hta10180.
8
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
9
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
10
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.

引用本文的文献

1
Dysregulation of the BRD2-FGF17 Signal Pathway Induces Abnormal Forebrain Development Associated with Schizophrenia.BRD2-FGF17信号通路失调诱导与精神分裂症相关的前脑发育异常。
Neurosci Bull. 2025 Sep 14. doi: 10.1007/s12264-025-01500-6.
2
The Potential of Hair Matrix for Biomarker Analysis in Schizophrenia.毛发基质用于精神分裂症生物标志物分析的潜力
Int J Mol Sci. 2025 Sep 7;26(17):8718. doi: 10.3390/ijms26178718.
3
Comprehensive Analysis of the Microbiome and Metabolome: Unveiling Interactions Between Intestinal Flora and Metabolites in Schizophrenia.
微生物组与代谢组的综合分析:揭示精神分裂症中肠道菌群与代谢物之间的相互作用
Neuropsychiatr Dis Treat. 2025 Sep 5;21:1955-1971. doi: 10.2147/NDT.S523570. eCollection 2025.
4
The role of mindfulness training supported by virtual reality in the nonpharmacological treatment of schizophrenia-research design.虚拟现实支持的正念训练在精神分裂症非药物治疗中的作用——研究设计
Ann Gen Psychiatry. 2025 Aug 13;24(1):49. doi: 10.1186/s12991-025-00587-5.
5
To Fly, or Not to Fly, That Is the Question: A Deep Learning Model for Peptide Detectability Prediction in Mass Spectrometry.飞行,还是不飞行,这是个问题:一种用于质谱中肽段可检测性预测的深度学习模型。
J Proteome Res. 2025 Jun 6;24(6):2709-2726. doi: 10.1021/acs.jproteome.4c00973. Epub 2025 May 9.
6
Discovery of biological markers for schizophrenia based on metabolomics: a systematic review.基于代谢组学的精神分裂症生物标志物发现:一项系统综述
Front Psychiatry. 2025 Mar 28;16:1540260. doi: 10.3389/fpsyt.2025.1540260. eCollection 2025.
7
Lipidomics and genomics in mental health: insights into major depressive disorder, bipolar disorder, schizophrenia, and obsessive-compulsive disorder.精神卫生领域的脂质组学与基因组学:对重度抑郁症、双相情感障碍、精神分裂症及强迫症的见解
Lipids Health Dis. 2025 Mar 11;24(1):89. doi: 10.1186/s12944-025-02512-x.
8
Quantitative analysis of literature on diagnostic biomarkers of Schizophrenia: revealing research hotspots and future prospects.精神分裂症诊断生物标志物文献的定量分析:揭示研究热点与未来前景
BMC Psychiatry. 2025 Mar 1;25(1):186. doi: 10.1186/s12888-025-06644-3.
9
Dysbiosis and Metabolic Dysregulation of Salivary Microbiota in Schizophrenia.精神分裂症患者唾液微生物群的生态失调与代谢紊乱
J Multidiscip Healthc. 2025 Feb 12;18:813-825. doi: 10.2147/JMDH.S504325. eCollection 2025.
10
Uncovering metabolic dysregulation in schizophrenia and cannabis use disorder through untargeted plasma lipidomics.通过非靶向血浆脂质组学揭示精神分裂症和大麻使用障碍中的代谢失调。
Sci Rep. 2024 Dec 28;14(1):31492. doi: 10.1038/s41598-024-83288-5.